Allocations
FRVR, a Malta-based HTML5 games publisher for both chat and post-app store platforms such as Facebook Messenger, has secured USD3 million in a seed investment led by Accel.
Makers Fund and angel investors, including games industry luminaries Paul Heydon and David Helgason, also participated in the round.
The way consumers engage with gaming and entertainment media is rapidly changing, with users’ time at an all-time premium.
As a result, there has been a rapid rise in the post-app store games market, comprising a multitude of new game distribution channels. The likes of Facebook Messenger, WeChat and Telegram have
Law firm Paul Hastings has represented Abry Partners II, a media, communications, business and information services focused private equity investment firm, on its disposal of Basefarm Holding AS to the Orange Group, for a total consideration of USD350 million.
This is Paul Hastings’ second deal this month for Abry, following their acquisition of Link Mobility Group.
Basefarm is a leading provider of complex managed services and technology advice in relation to big data, cloud computing and information security, operating in Norway, Germany, Sweden and the Netherlands.
The Paul Hastings team included corporate partners Anu Balasubramanian and Garrett Hayes and senior associate David Prowse, tax
BGF has backed tech-focused Click Travel, a business travel management company, with a multi-million pound investment. This follows a sustained period of technological advances and new client wins.
Headquartered in Birmingham, the business was founded in 1999 by brothers Simon McLean, CTO and James McLean, CFO. Click Travel’s proprietary technology platform, travel.cloud, provides the look, feel and usability of a consumer site alongside services that help businesses reduce the cost and complexity of business travel.
Offering support across hotels, flights, rail, meetings and events, Click Travel manages millions of travel bookings a year for a wide variety of businesses
Salveo Capital, an alternative investment firm specialising in the legalised cannabis space, has acquired a minority equity interest in PathogenDx, a provider of DNA-based pathogen testing kits for the cannabis, botanical, food and agriculture industries.
Financial terms of the transaction have not been disclosed.
Founded in 2014, PathogenDx’s mission is to deliver disruptive testing technology and solutions to the cannabis, botanical, food and agricultural testing markets that provide breakthrough simplicity, and cost-effectiveness, at an adaptable scale for both large and small testing facilities. The company’s technology offers growers, processors, producers, consumers and ancillary service providers within the botanical, food
Stockholm IT Ventures, a Swedish technology company specialising in energy crypto currency mining, has secured a EUR2 million investment in its Bytemine token (BYTM) from Pecunio’s VC Fund.
Pecunio, a fintech company in the United Arab Emirates, has also offered to purchase the remaining allocation of Bytemine tokens (up to EUR 1 million) by the end of the sale.
“We are extremely excited to have Pecunio on board as an institutional investor,” says Phillip Nunn, Managing Director of the Crypto Division for Stockholm IT Ventures. “Being recognised and added to Pecunio’s exclusive portfolio represents a great testament to our
Avedon Capital Partners has sold Robidus, a provider of social security services and software in the Netherlands, to Aegon, a life insurance, pensions and asset management company headquartered in The Hague, Netherlands.
Closing is subject to regulatory and workers’ council approvals.
Both the Robidus Management and Avedon are pleased with this transaction, which confirms the value creation strategy that has been actively pursued in partnership since 2015.
Founded in 2003 and based in the Netherlands, Robidus has built highly specialised domain expertise to help Dutch employers execute their tasks and responsibilities regarding employee absence and disability as required
Law firm Trowers & Hamlins has advised founders Daniel and Thomas Lowe, on the sale of Fourpure, a Bermondsey based craft brewer brand, to the UK subsidiary of Lion Pty, a large international FMCG company based in Australia.
Set up by brothers Daniel and Thomas Lowe in 2013, Fourpure supplies brands including Session IPA and Pils Lager to larger stores such as Marks & Spencer and Tesco as well as independent outlets.
Trowers corporate partner Nick Harrisingh says: “It was a pleasure to successfully complete another transaction for Daniel and Thomas. The Fourpure brand has grown significantly since its origin and
UK private equity firm Sovereign Capital Partners has exited investment in Xendo – an independent consultancy and project management organisation in the of (bio)pharmaceutical products, medical devices and healthcare space – to ProPharma Group, a portfolio company of US-based Linden Capital Partners.
This is Sovereign’s third exit in recent weeks and swiftly follows the sale of veterinary services provider Linnaeus Group to Mars Petcare’s Veterinary Health Group, and accident management services business Kindertons to ExamWorks. Xendo is also Sovereign’s first exit from its GBP395m fund SCLP IV.
Sovereign originally completed the management buy-out of Xendo in 2016. During the
Palamon Capital Partners (Palamon), a pan-European growth investor, has acquired a majority stake in FairConnect, a provider of connected insurance services.
Palamon and its financing partners have invested and committed more than EUR100 million of funding to the Company.
FairConnect is a leading provider of connected services to insurers that are transforming the insurance industry with usage-based premiums and value-added services. For example, customers with “connected motor insurance” can benefit from reduced premiums and access a range of new services (such as accident and emergency assistance, breakdown diagnostics and theft recovery) which is driving rapid growth in the sector of
Nexus Investments, a division of Harry Hyman’s Nexus Group, has launched its first EIS Scale-Up Fund which it believes to be the first of its kind since the June announcement of the UK Government’s GBP2.5 billion British Patient Capital programme.
The Fund aims to address a large gap in the market by providing UK investors with access to exciting but curated UK entrepreneur-led private companies that have successfully passed the start-up stage and are ready to scale up on a global basis.
It will focus on four of the most exciting areas of change in the world today where
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
